Search

everythinglearnresearchcommunity

for

Search:↓

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

ΔNp63α helps control a protein that stops cancer cells from spreading.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

A microneedle patch can help regrow hair by restoring immune balance in hair follicles.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

CS12192 effectively treats alopecia areata with better safety than current options.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Upadacitinib may effectively treat resistant lichen planopilaris.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

A specific group of early-stage melanocytes is reduced in vitiligo-affected skin, which may explain treatment resistance.

Ritlecitinib can help about 14,000 people with severe hair loss.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

IVL3001 is safe, effective, and better than oral finasteride for treating hair loss.

Nilotinib can cause generalized keratosis pilaris.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Pulsed electric field treatment may help the immune system fight liver tumors.